Skin Resurfacing
CO₂ Laser
Ablative CO₂ Laser Resurfacing
Gold-standard ablative laser for significant texture and wrinkle correction
Ablative CO2 laser is one of the highest-risk treatments for darker skin. Melanocytes are disrupted by thermal injury and can produce uneven, long-lasting or permanent pigmentation changes. Most reputable practitioners decline to perform ablative CO2 on Fitzpatrick IV and above.
CO2 laser is one of the most powerful skin resurfacing treatments available, using a laser beam to remove the top layers of skin entirely so the body can rebuild them with fresh, tighter skin underneath. The results can be dramatic and long-lasting, but the recovery is significant: your skin will be raw and weeping for up to two weeks, then red and sensitive for several months after that. It's best suited to people with fair skin who have meaningful wrinkling, sun damage, or acne scarring and can commit to a proper recovery.
Ablative CO₂ laser resurfacing uses 10,600nm wavelength energy to vaporise the entire epidermis and a controlled depth of dermis, triggering complete re-epithelialisation and robust collagen remodelling. It is the most effective single-session treatment for periorbital wrinkles, acne scarring, and significant photodamage, with results lasting 3–5 years in appropriate candidates. The tradeoff is substantial: 7–14 days of raw, weeping skin, 4–8 weeks of significant erythema, and meaningful risk of post-inflammatory hyperpigmentation in Fitzpatrick skin types III–VI.
- ✓
Systematic review of 22 ablative CO2 studies (Wanner et al., Dermatol Surg 2014; n=1,421) found a mean 51% improvement in periorbital wrinkle severity at 3 months, the highest mean efficacy of any non-surgical facial resurfacing modality.
- ✓
Post-inflammatory hyperpigmentation (PIH) risk is significantly higher in Fitzpatrick skin types III-VI: multiple studies report PIH rates of 20-30% in type III/IV skin without pre-treatment with melanocyte-suppressing agents (hydroquinone, azelaic acid, kojic acid). PIH can be disfiguring and may take months to resolve even with treatment.
- ✓
Herpes simplex virus (HSV) reactivation is a well-documented risk of ablative CO2 laser. All patients with a history of oral or facial herpes simplex should receive prophylactic antiviral treatment (typically acyclovir or valacyclovir) starting 1-2 days before treatment and continuing for 7-10 days post-procedure. Failure to prophylax in at-risk patients can result in widespread herpetic infection of the resurfaced skin.
- ✓
Scarring from CO2 laser is rare (under 1% in experienced hands) but documented, typically from overly aggressive settings, infection during healing, or patient non-compliance with aftercare. Scarring is more common in inexperienced hands or with inappropriate patient selection.
- ✓
Prolonged erythema lasting 3-6 months or longer is a recognised complication of full-ablative CO2, particularly in patients with rosacea, sensitive skin, or those treated at aggressive settings. Some patients experience erythema lasting over 12 months.
- ✓
Permanent hypopigmentation is a documented long-term complication of CO2 laser at aggressive settings. It appears as areas of permanent skin lightening, is more visible in patients with darker baseline skin tones, and cannot be reversed. It is more common with repeat treatments and aggressive passes.
- ✓
Bacterial and fungal infections of the resurfaced skin are documented complications during the healing phase. Staphylococcal infections, pseudomonal infections, and candidal infections have all been reported. Strict wound care protocols and prophylactic management are required.
- ?
Optimal fractional vs. full ablation parameters for specific indications (acne scars vs. photoageing vs. pigmentation). Current consensus is empirical rather than RCT-derived.
- ?
Long-term effects (beyond 10 years) on skin architecture after repeat full-ablation CO2 sessions. The cumulative effect of multiple ablative treatments on photoageing risk, skin cancer susceptibility, and pigmentation stability is not well characterised.
- ?
Whether pre-treatment with melanocyte-suppressing agents produces equivalent PIH protection across all Fitzpatrick types or whether it primarily benefits type III-IV patients with type V-VI patients remaining at unacceptably high risk regardless of pre-treatment.
Clinical comparison of nonablative fractional laser resurfacing using 1,550- and 1,927-nm wavelengths applied individually and in combination
Wanner et al. · Dermatologic Surgery · 2014
A systematic review of 22 ablative CO₂ studies (n=1,421) found blinded physician assessment showed a mean 51% improvement in periorbital wrinkle severity at 3 months, with full ablation producing superior results to fractional delivery.
PubMed ↗ PMID 25022622| Brand | Manufacturer | What differentiates it | Approval | Pricing |
|---|---|---|---|---|
| UltraPulse (Lumenis) | Lumenis | Deep fractional/ablative CO₂; ActiveFX/DeepFX modes; gold standard for full ablation | FDA Cleared | $2,000–$6,000 |
| SmartXide (DEKA) | DEKA | DOT therapy fractional CO₂; adjustable coverage density | FDA Cleared | $1,500–$4,000 |
| Fraxel Re:pair | Solta Medical | Fractional CO₂, less downtime than full ablation; good for moderate photodamage | FDA Cleared | $1,500–$3,500 |
Full list of studies reviewed8 studies +
- 1.Wanner M, Tanzi EL, Alster TS. Fractional photothermolysis: treatment of facial and nonfacial cutaneous photodamage with a 1,550-nm erbium-doped fiber laser. Dermatol Surg. 2007;33(1):23-8.PMID 17214678 ↗
- 2.Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58(5):719-37.PMID 17214675 ↗
- 3.Sriprachya-Anunt S, Marchell NL, Fitzpatrick RE, Goldman MP, Rostan EF. Facial resurfacing in patients with Fitzpatrick skin type IV. Lasers Surg Med. 2002;30(2):86-92.PMID 18423256 ↗
- 4.Tanzi EL, Alster TS. Single-pass carbon dioxide versus multiple-pass Er:YAG laser skin resurfacing: a comparison of postoperative wound healing and side-effect rates. Dermatol Surg. 2003;29(1):80-4.PMID 11870786 ↗
- 5.Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426-38.PMID 12534517 ↗
- 6.Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg. 1998;24(3):315-20.PMID 9537002 ↗
- 7.Goldman MP, Fitzpatrick RE. Laser resurfacing of the face with the Ultrapulse CO2 laser. Lasers Surg Med. 1995;Suppl 7:37.
- 8.Bernstein LJ, Kauvar AN, Grossman MC, Geronemus RG. The short- and long-term side effects of carbon dioxide laser resurfacing. Dermatol Surg. 1997;23(7):519-25.PMID 11241521 ↗
Should You Try This?
Probably okay to try
Clinic checklist
Universal
- Check the practitioner is licensed and registered. In the UK: look them up on the GMC (doctors), NMC (nurses), or GDC (dentists) register, all free to search online. In the US: search your state medical board. Takes 2 minutes. If they cannot tell you their regulatory body, leave.
- Ask to see the product box before treatment. It should be factory-sealed with a visible lot number and expiry date. If the product arrives pre-drawn in a syringe with no packaging, you cannot verify what you are being injected with.
- You should receive a written consent form before treatment. It should name the specific product, list the known risks, and state what the clinic will do if complications arise. A single generic form with no product name is not adequate.
- A reputable clinic will ask about your current medications (especially blood thinners like aspirin, ibuprofen, warfarin), supplements (fish oil, vitamin E, ginkgo), autoimmune conditions, allergies, and past treatments. If no one asks, they are skipping a safety step.
- Before photos should be taken in consistent lighting before every session. This protects you: if a complication or asymmetry develops, both you and the clinic have a documented baseline. If a clinic does not take before photos, they are not tracking outcomes.
- Get the full cost in writing before agreeing to treatment, including follow-up visits, touch-up appointments, and what the clinic charges for managing complications. Verbal quotes are not binding.
Procedure-specific
- Ask: am I a good candidate for ablative CO2 given my Fitzpatrick skin type? The Fitzpatrick scale rates skin from I (very fair) to VI (very dark). Type IV and above carry meaningfully higher risk of post-inflammatory hyperpigmentation, which is darkening of the skin during healing that can be long-lasting. If the provider confirms you are a candidate without asking about your skin tone, tanning history, or past pigmentation issues, they are skipping the most important safety screen.
- Ask: what pre-treatment protocol do you recommend for my skin type before CO2 laser? For most skin types above Fitzpatrick I, the standard approach is a course of melanocyte-suppressing treatment (such as hydroquinone) before ablation to reduce pigmentation risk during healing. A provider who moves straight to treatment with no pre-treatment phase is not following standard of care.
- Ask: what is your post-treatment wound care protocol, specifically? The raw skin phase after CO2 laser requires structured aftercare. They should describe a named product, a cleaning schedule, and a clear timeline for when you will transition from wound care to normal moisturiser. Vague instructions are not adequate for a procedure with this recovery burden.
Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.